QuarterWatch analyzes MedWatch Reports

This issue of QuarterWatch analyzes MedWatch Reports from the third quarter of 2015. This issue identifies major differences in reports of cancer associated with drugs for psoriasis, a common skin disorder affecting an estimated 7.5 million people. While corticosteroid and other topical drugs are sufficient for many cases, potent immunosuppressant drugs are used in increasing numbers. This report also provides new evidence that drugs for erectile dysfunction and pulmonary arterial hypertension can cause deafness or sudden hearing loss.

To read this article, please click here.

Posted in

More RSI News

RSI partners with Engineers Canada to offer Online Workshop on the PIEVC Protocol

February 6, 2019
RSI logo in white

RSI and Engineers Canada are partnering to offer an online version of the introductory workshop on the PIEVC Protocol for infrastructure climate risk and vulnerability…

Read News Item

RSI contributes to newly published book on Blood Safety.

October 31, 2018
RSI contributed to Blood Safety, A Guide to Monitoring and Responding to Potential New Threats

Written by experts in the field, Blood Safety: A Guide to Monitoring and Responding to Potential New Threats offers a concise yet comprehensive overview on critical issues in monitoring…

Read News Item

RSI Provides Technical Advice and Review to Vietnam Partners and on-site Climate Support for Workshop

October 26, 2018
RSI logo in white

Engineers Canada is a partner with the German development agency Deutsche Gesellschaft für Internationale Zusammenarbeit GmbH (GIZ) in the execution of their Enhanced Climate Services…

Read News Item

Neil Comer to present at OPTrust Climate Change Symposium

October 15, 2018
RSI logo in white

The OPTrust Climate Change Symposium being held NOVEMBER 19-20, 2018 in TORONTO offers an opportunity to provide new insights into how to face climate change…

Read News Item